Polymerised liposome vaccine delivery systemAlternative Names: Orasome
Latest Information Update: 28 Aug 2007
At a glance
- Originator Nonindustrial source
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 16 Jun 2000 Endorex has received an additional US patent for the Orasome delivery system
- 12 Jun 1998 Preclinical development for Undefined in USA (Parenteral)